ArticleSAGE open medicine2019

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System.

Misa Naganuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.